Effectiveness of Inspiratory Muscle Training on Dyspnea and Fatigue among Critically-Ill Burn Patients Receiving High-Flow Nasal Oxygen Therapy: A Randomized Controlled Trial
Trial Snapshot
- Phase
- Unknown
- Status
- Completed
- Sponsor
- Enrollment
- 56
- Locations
- 1
- Primary Endpoint
- Dyspnea
Study Overview
Brief Summary
- To evaluate the effectiveness of inspiratory muscle training on dyspnea among critically ill burn patients receiving high-flow nasal oxygen therapy (pre-post test).
- To evaluate the effectiveness of inspiratory muscle training on fatigue among critically ill burn patients receiving high-flow nasal oxygen therapy (pre-post test).
- To find out the relationship between effectiveness inspiratory muscle training and patients’ sociodemographic data.
Study Design
- Study Type
- Interventional
- Primary Purpose
- 随机平行对照
- Masking
- None
Eligibility Criteria
- Ages
- 18 to 65 (—)
- Sex
- All
Inclusion Criteria
- •1.18–65 years old adults;
- •2.Second- or third-degree burn with >=20% TBSA;
- •3.Stable and cooperative;
- •4.Under high-flow nasal oxygen therapy (HFNC);
- •5.Maximum Inspiratory Pressure (MIP) Ranges between 9 and 41 cmH2O.
Exclusion Criteria
- •1.Unstable chronic cardiovascular or respiratory diseases.
- •2.Present acute respiratory infections.
- •3.Mental or physical incapability for performing IMT.
- •4.Receipt of other therapies having an effect upon the study outcomes.
- •5.Maximum Inspiratory Pressure (MIP) Ranges under 9_ above 41 cmH₂O.
Arms & Interventions
Control group
Conventional care
Intervention group
Conventional care and inspiratory muscle training intervention (The inspiratory muscle training protocol used in the present study was designed and implemented in accordance with evidence-based respiratory rehabilitation guidelines, including the recommendations of the American Thoracic Society and the European Respiratory Society for respiratory muscle training, as well as contemporary clinical practice guidelines for the respiratory management of critically ill and burn patients receiving high-flow nasal oxygen therapy.)
Outcomes
Primary Outcomes
Dyspnea
Time Frame: one days and fourteen days after the intervention
Fatigue
Time Frame: one days and fourteen days after the intervention
Secondary Outcomes
No secondary outcomes reported
